Ovid Therapeutics Inc. (OVID) vs Senseonics Holdings, Inc. (SENS)

A side-by-side comparison of Ovid Therapeutics Inc. and Senseonics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OVID vs SENS

growth of $100 · dividends reinvested · last 9y
OVID -80.9% (-16.8%/yr)SENS -68.6% (-12.1%/yr)SENS compounded faster over this window
0100200300Start $1002019202120232025$19$31
OVID SENS

OVID vs SENS: by the numbers

  • •OVID is the larger company ($449M vs $419M market cap).
  • •Both run net losses; SENS's is the smaller (-225.34% vs -2178.90% net margin).
  • •SENS grew revenue faster over the past five years (35.10% vs -62.76% CAGR).

Metrics side by side

Valuation

MetricOVIDSENS
P/S ratio283.348.63
P/B ratio2.144.64

Profitability

MetricOVIDSENS
Gross margin100.00%44.71%
Operating margin-585.20%-193.83%
Net margin-2178.90%-225.34%
ROE-16.43%-121.12%
ROIC-26.29%-71.22%

Growth (annualized)

MetricOVIDSENS
Revenue CAGR (5Y)-62.76%35.10%
Total return CAGR (5Y)-6.98%-30.89%

Frequently asked

Which has grown faster, OVID or SENS?
Over the past five years, SENS grew revenue faster — OVID at a -62.76% CAGR versus SENS at 35.10%.
How have OVID and SENS total returns compared?
Over the past 5 years, OVID delivered -6.98% and SENS delivered -30.89% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.